01

Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. Wangsa D, Heselmeyer-Haddad K, Ried T, et al. Am J Pathol. 2009 Dec;175(6): 2637-2645.

02

Detection of Genomic Amplification of the Human Telomerase Gene TERC, a Potential Marker for Triage of Women with HPV-Positive, Abnormal Pap Smears. Andersson S, Sowjanya P, Ried T, et al. Am J Pathol. 2009 Nov;175(5): 1831-1847.

03

Spectral karyotyping analysis of human and mouse chromosomes. Padilla-Nash HM, Barenboim-Stapleton L, Difilippantonio MJ, Ried T. Nature Protocols. 2006;1(6): 3129-3142

04

Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T. Am J Pathol. 2005 Apr;166(4):1229-38.

05

Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, Morrison LE, Auer G, Burroughs FH, Sherman ME, Ried T. Am J Pathol. 2003 Oct;163(4): 1405-16.

06

Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. Difilippantonio MJ, Petersen S, Chen HT, Johnson R, Jasin M, Kannar R, Ried T, Nussenzweig A. J Exp Med. 2002 Aug 19;196(4):469-80.

07

Fluorescent in situ hybridization studies in multiple myeloma. Yuregir OO, Sahin FI, Yilmaz Z, Kizilkilic E, Karakus S, Ozdogu H. Hematology. 2009 Apr;14(2):90-4.

08

Specialized Fluorescence In Situ Hybridization (FISH) Techniques for Leukaemia Research. Kearney L, Colman S. Methods Mol Biol. 2009;538:1-14.

09

Fluorescence In Situ Hybridization (FISH)-Application Guide Edited by Thomas Liehr 2008

10

Fluorescence in situ hybridization for prenatal screening of chromosomal aneuploidies. Weise A, Liehr T. Expert Rev Mol Diagn. 2008 Jul;8(4):355-7.

11

Fluorescence in situ hybridization in diagnostic cytology. Halling KC, Kipp BR. Hum Pathol. 2007 Aug;38(8):1137-44.

12

Multiplex-FISH (M-FISH): technique, developments and applications. Kearney L. Cytogenet Genome Res. 2006;114(3-4):189-98.

13

Fluorescent in situ hybridization and array comparative genomic hybridization: complementary techniques for genomic evaluation. Morrison C. Arch Pathol Lab Med. 2006 Jul;130(7):967-74.

14

Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia. Landstrom AP, Tefferi A. Leuk Lymphoma. 2006 Mar;47(3):397-402.

15

Applications of fluorescence in situ hybridization in cytopathology: a review. Oliveira AM, French CA. Acta Cytol. 2005 Nov-Dec;49(6):587-94.

16

Multi-color FISH techniques. Bayani J, Squire J. Curr Protoc Cell Biol. 2004 Oct;Chapter 22:Unit 22.5.

17

Fluorescence in situ Hybridization (FISH). Bayani J, Squire JA. Curr Protoc Cell Biol. 2004 Sep;Chapter 22:Unit 22.4.

18

Diagnosis of microdeletion syndromes by fluorescence in situ hybridization (FISH). Shaffer LG. Curr Protoc Hum Genet. 2001 May;Chapter 8:Unit 8.10

19

Cytogenetics as an aid in the diagnosis of lymphomas. Glassman AB, Hopwood V, Hayes KJ. Ann Clin Lab Sci. 2000 Jan;30(1):72-4.

20

Multicolor spectral karyotyping of human chromosomes. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. Science. 1996 273, 494-497.

01

Jesse M Jaso, C Cameron Yin1, Victoria W Lu1, Ming Zhao1, Lynne V Abruzzo, M James You, Yaling Yang, Raja Luthra, L Jeffrey Medeiros and Gary Lu. B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease. Modern Pathology 27(3): 382-9 (2013). http://www.nature.com/doifinder/10.1038/modpathol.2013.149

http://www.ncbi.nlm.nih.gov/pubmed/24030742

02

Lee JC, Jeng YM, Su SY, Wu CT, Tsai KS, Lee CH, Lin CY, Carter JM, Huang JW, Chen SH, Shih SR, Mariño-Enríquez A, Chen CC, Folpe AL, Chang YL, Liang CW. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol. 235(4):539-45 (2015). doi: 10.1002/path.4465.

http://www.ncbi.nlm.nih.gov/pubmed/25319834

03

Jen-Chieh Lee, Sheng-Yao Su, Chun A Changou, Rong-Sen Yang, Keh-Sung Tsai, Michael T Collins, Eric S Orwoll, Chung-Yen Lin, Shu-Hwa Chen, Shyang-Rong Shih, Cheng-Han Lee, YoshinaoOda, Steven D Billings, Chien-Feng Li, G Petur Nielsen, Eiichi Konishi, Fredrik Petersson, Thomas O Carpenter, Kesavan Sittampalam, Hsuan-Ying Huang and Andrew L Folpe. Characterization of FN1–FGFR1 and novel FN1–FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Modern Pathology, Jul 22 , 1–12 (2016) [Epub ahead of print]  doi: 10.1038/modpathol.2016.137

http://www.ncbi.nlm.nih.gov/pubmed/27443518

04

Collins, M., et al. Striking Response of Tumor-Induced Osteomalacia to the FGFR Inhibitor NVP-BGJ398. Journal of Bone and Mineral research, LB-SA0035 (2015).

http://meetinglibrary.asco.org/content/168898-176

05

J. A. Berglund, R. I. Gafni, F. Wodajo, E. W. Cowen, D. El-Maouche, R. Chang, C. C. Chen, L. C. Guthrie, A. A. Molinolo, & M. T. Collins. Tumor-induced osteomalacia in association with PTEN-negative Cowden syndrome. Osteoporosis International 29(4):993-997 (2018). DOI: 10.1007/s00198-017-4372-x

https://www.ncbi.nlm.nih.gov/pubmed/29380000

06

Sent-Doux KN, Mackinnon C, Lee JC, Folpe AL, Habeeb O. Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization. Hum. Pathol. 80:94-98 (2018). doi: 10.1016/j.humpath.2018.02.022.

https://www.ncbi.nlm.nih.gov/pubmed/29514106

01

Petrovics G, Li H, Stümpel T, Tan SH, Young D, Katta S, Li Q, Ying K, Klocke B, Ravindranath L, Kohaar I, Chen Y, Ribli D, Grote K, Zou H, Cheng J, Dalgard CL, Zhang S, Csabai I, Kagan J, Takeda D, Loda M, Srivastava S, Scherf M, Seifert M, Gaiser T, McLeod DG, Szallasi Z, Ebner R, Werner T, Sesterhenn IA, Freedman M, Dobi A, Srivastava S. A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men. EBioMedicine 2(12):1957-64 (2015). doi: 10.1016/j.ebiom.2015.10.028.

http://www.ncbi.nlm.nih.gov/pubmed/26844274

02

Albert Dobi, Gyorgy Petrovics, Hua Li, Shyh-Han Tan, Tanja Stümpel, Denise Young, Shilpa Katta, Qiyuan Li, Kai Ying, Bernward Klocke, Lakshmi Ravindranath, Indu Kohaar, Yongmei Chen, Dezső Ribli, Korbinian Grote, Hau Zou, Joseph Cheng, Clifton L. Dalgard, Shimin Zhang, István Csabai, Jacob Kagan, David Takeda, Massimo Loda, Sudhir Srivastava, Matthias Scherf, Martin Seifert, Timo Gaiser, David G. McLeod, Zoltan Szallasi, Reinhard Ebner, Thomas Werner, Isabell A. Sesterhenn, Matthew Freedman, Shiv Srivastava. LSAMP gene deletion is associated with rapid disease progression in prostate cancer of African American men [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; 2016. Abstract nr 140.

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=4017&sKey=f78afb44-80bf-4b93-ab18-47ce2eee6d54&cKey=1bab1eec-d02f-4fd5-a66e-e4496eeaec84&mKey=1d10d749-4b6a-4ab3-bcd4-f80fb1922267

03

Shyh-Han Tan, Gyorgy Petrovics, Hua Li, Tanja Stümpel, Denise Young, Shilpa Katta, Qiyuan Li, Xiamen, Kai Ying, Bernward Klocke, Lakshmi Ravindranath, Indu Kohaar, Yongmei Chen, Dezso Ribli, Korbinian Grote, Hua Zou, Joseph Cheng, Clifton L. Dalgard, Shimin Zhang, István Csabai, Joseph Kagan, David Takeda, Massimo Loda, Sudhir Srivastava, Matthias Scherf, Martin Seifert, Timo Gaiser, David G. McLeod, Zoltan Szallasi, Reinhard Ebner, Thomas Werner, Isabell A. Sesterhenn, Matthew Freedman, Albert Dobi, Shiv Srivastava.

A Novel Deletion of the LSAMP Gene Locus Associates with Rapid Progression of Prostate Cancer among African American Men

The Journal of Urology, Vol. 195, No. 4S, Supplement, abstract cr. MP-05 (2016).

http://www.jurology.com/article/S0022-5347(16)01567-6/abstract

04

Albert Dobi, Gyorgy Petrovics, Shyh-Han Tan, Hua Li, Denise Young, Cara Schafer, Jesse Fox, Kevin Babcock, Heng-Cheng Hu, Gauthaman Sukumar, Yingjie Song, Lakshmi Ravindranath, Yongmei Chen, Joseph Cheng, Reinhard Ebner, Qingyu Xiao, Yidi Sun, Hong Li, Yixue Li, Yuan Ji, Jun Hou, Wendy Wang, Guo-Ping Zhao, Jacob Kagan, Sudhir Srivastava, Joel T. Moncur, Clifton L. Dalgard, Matthew Wilkerson, Inger L. Rosner, Jennifer Cullen, Matthew Freedman, Zoltan Szallasi, Isabell A. Sesterhenn, Shiv Srivastava. Racial/ethnic Differences in Prostate Cancer Genomic Alterations. 

AACR Annual Meeting 2018 in Chicago, Illinois 

Wednesday Apr 18, 2018 8:00 AM - 12:00 PM 

Permanent Abstract Number: 5352"

http://www.abstractsonline.com/pp8/#!/4562/presentation/7167

01

Zhaomin Wang. Distinct Genomic Alterations in Prostate Tumors from African American Men. EBioMedicine, November 2015 (http://dx.doi.org/10.1016/j.ebiom.2015.11.032).

http://www.ncbi.nlm.nih.gov/pubmed/26844255